These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 1977698)

  • 1. Nitric oxide. A novel signal transduction mechanism for transcellular communication.
    Ignarro LJ
    Hypertension; 1990 Nov; 16(5):477-83. PubMed ID: 1977698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling.
    Ignarro LJ
    Pharmacol Toxicol; 1990 Jul; 67(1):1-7. PubMed ID: 1975691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heme-dependent activation of guanylate cyclase by nitric oxide: a novel signal transduction mechanism.
    Ignarro LJ
    Blood Vessels; 1991; 28(1-3):67-73. PubMed ID: 1672101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide and cytosolic guanylate cyclase: components of an intercellular signalling system.
    Böhme E; Schmidt HH
    Z Kardiol; 1989; 78 Suppl 6():75-9. PubMed ID: 2575829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cytosolic guanylyl cyclase by porphyrins and metalloporphyrins.
    Ignarro LJ
    Adv Pharmacol; 1994; 26():35-65. PubMed ID: 7913618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Halothane and isoflurane inhibit endothelium-derived relaxing factor-dependent cyclic guanosine monophosphate accumulation in endothelial cell-vascular smooth muscle co-cultures independent of an effect on guanylyl cyclase activation.
    Johns RA; Tichotsky A; Muro M; Spaeth JP; Le Cras TD; Rengasamy A
    Anesthesiology; 1995 Oct; 83(4):823-34. PubMed ID: 7574063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of soluble guanylate cyclase in the molecular mechanism underlying the physiological effects of nitric oxide.
    Severina IS
    Biochemistry (Mosc); 1998 Jul; 63(7):794-801. PubMed ID: 9721331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
    Mellion BT; Ignarro LJ; Myers CB; Ohlstein EH; Ballot BA; Hyman AL; Kadowitz PJ
    Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium-derived nitric oxide: pharmacology and relationship to the actions of organic nitrate esters.
    Ignarro LJ
    Pharm Res; 1989 Aug; 6(8):651-9. PubMed ID: 2510139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular nitric oxide: Beyond eNOS.
    Zhao Y; Vanhoutte PM; Leung SW
    J Pharmacol Sci; 2015 Oct; 129(2):83-94. PubMed ID: 26499181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine 3',5'-monophosphate formation by preparations of rat liver soluble guanylate cyclase activated with nitric oxide, nitrosyl ferroheme, S-nitrosothiols, and other nitroso compounds.
    McNamara DB; Kadowitz PJ; Hyman AL; Ignarro LJ
    Can J Physiol Pharmacol; 1980 Dec; 58(12):1446-56. PubMed ID: 6113040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nitric oxide. The role of guanylate cyclase in its physiological effects].
    Severina IS
    Vopr Med Khim; 2002; 48(1):4-30. PubMed ID: 12068497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide.
    Onoue H; Katusic ZS
    Brain Res; 1998 Feb; 785(1):107-13. PubMed ID: 9526059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide from vascular smooth muscle cells: regulation of platelet reactivity and smooth muscle cell guanylate cyclase.
    Mollace V; Salvemini D; Anggard E; Vane J
    Br J Pharmacol; 1991 Nov; 104(3):633-8. PubMed ID: 1724627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase.
    Boulton CL; Southam E; Garthwaite J
    Neuroscience; 1995 Dec; 69(3):699-703. PubMed ID: 8596640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiology and pathophysiology of nitric oxide.
    Ignarro LJ
    Kidney Int Suppl; 1996 Jun; 55():S2-5. PubMed ID: 8743501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin.
    Fleming I; Julou-Schaeffer G; Gray GA; Parratt JR; Stoclet JC
    Br J Pharmacol; 1991 May; 103(1):1047-52. PubMed ID: 1678981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction system.
    Murad F
    Adv Pharmacol; 1994; 26():19-33. PubMed ID: 7913616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium-derived nitric oxide: actions and properties.
    Ignarro LJ
    FASEB J; 1989 Jan; 3(1):31-6. PubMed ID: 2642868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.